JSJessyca Luana Melo Costa Santos

Jessyca Luana Melo Costa Santos

*This is an algorithmically generated author record based on publicly available information.

Jessyca Luana Melo Costa Santos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of red light photobiomodulation (630nm) on L929 fibroblasts: a preliminary in vitro study

    by G.T.A. Silva, J.L.M.C. Santos, P.G. Oliveira, M.A.P. Oliveira, V.S. Franzo, L.P. Oliveira, J.L.S. Nascimento, V.A.S. Vulcani

    Photobiomodulation (PBM) is a noninvasive and promising therapeutic approach that has attracted growing attention for its potential applications in tissue regeneration and wound healing. In this in vitro study, we investigated the biological effects of red LED light (wavelength 630nm) on L929 fibroblasts, focusing on cell viability, nitric oxide (NO) production, and collagen synthesis. Cells were exposed to varying power intensities (50, 75, and 100mW) and irradiation durations (5 and 10 seconds). PBM did not compromise cell viability under any of the tested conditions. On the contrary, it significantly stimulated both NO production and collagen synthesis, particularly at higher power settings and longer exposure times. These findings demonstrate that red light can enhance fibroblast metabolic activity, which is essential for effective tissue repair. Therefore, PBM appears to be a valuable and safe therapeutic tool for regenerative medicine. Further in vivo investigations are needed to optimize PBM parameters and confirm their clinical relevance.

  • Open Access

    The ineffectiveness of antimicrobial photodynamic therapy in the absence of preincubation of the microorganisms in the photosensitizer

    by Ítalo Dany Cavalcante Galo, Jéssica Assis Carvalho, Jessyca Luana Melo Costa Santos, Alexandre Braoios, Rodrigo Paschoal Prado

    Introduction: Considering its potential as an alternative therapy to combat multiresistant bacteria, photodynamic therapy has been improved and better studied in recent years, and determining its optimized application patterns is important. Objective: This study aimed to evaluate the action of antimicrobial photodynamic therapy mediated by methylene blue in the absence of preincubation of infectious agents in the photosensitizer. Method: Standard strains of Staphylococcus aureus and Pseudomonas aeruginosa were used, which was or was not submitted to two methylene blue concentrations (0.1 μg/mL and 500 mg/mL) applied alone or in combination with a variety of red laser emission parameters (660 nm); in both cases, the streak was performed immediately after mixing between the photosensitizer and the solution containing the bacteria. Results: In the dishes with only methylene blue application neither antibacterial was produced, nor inhibition at the application points of the photodynamic therapy in the case of the bacterium Pseudomonas aeruginosa. However, in the cultures of Staphylococcus aureus in which laser emission was associated with the concentration of 500 mg/mL of the photosensitizer, inhibition was present at the laser application points. Conclusion: The time of exposure to the photosensitizer prior to the application of phototherapy seems to be an essential factor for the optimized action of photodynamic therapy, especially in the case of Gram-negative bacteria.